Last $17.98 USD
Change Today +0.11 / 0.62%
Volume 67.4K
OXFD On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

oxford immunotec global plc (OXFD) Snapshot

Open
$17.76
Previous Close
$17.87
Day High
$18.05
Day Low
$17.76
52 Week High
03/6/14 - $25.38
52 Week Low
11/22/13 - $13.58
Market Cap
310.4M
Average Volume 10 Days
43.9K
EPS TTM
--
Shares Outstanding
17.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OXFORD IMMUNOTEC GLOBAL PLC (OXFD)

Related News

No related news articles were found.

oxford immunotec global plc (OXFD) Related Businessweek News

No Related Businessweek News Found

oxford immunotec global plc (OXFD) Details

Oxford Immunotec Global PLC, a diagnostics company, focuses on the provision of various tests in the field of immunology in the United States, Europe, Japan, and China. The company develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immunologically controlled diseases. Its solution includes SPOT.TB test, a single-cell based method for identifying latent tuberculosis infection. The company was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

157 Employees
Last Reported Date: 03/27/14
Founded in 2002

oxford immunotec global plc (OXFD) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $303.4K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $225.5K
Chief Commercial Officer
Total Annual Compensation: $272.7K
Compensation as of Fiscal Year 2012.

oxford immunotec global plc (OXFD) Key Developments

Oxford Immunotec Global PLC Announces Unaudited Consolidated Earnings Results for Fourth Quarter and Full Year Ended December 31, 2013; Provides Earnings Guidance for First Quarter and Full Year of 2014

Oxford Immunotec Global PLC announced unaudited consolidated earnings results for fourth quarter and full year ended December 31, 2013. For the quarter, the company reported revenues were $10.2 million, representing 94% growth over 2012 fourth quarter revenues of $5.3 million. LBITDA was $2.7 million compared to $4.2 million in the fourth quarter of 2012. Adjusted LBITDA was $1.4 million compared to $4.1 million in the same period in 2012. EBITDA and Adjusted EBTIDA are non-GAAP financial measures. Net loss was $3.3 million or $0.38 per share compared to $4.3 million or $1.99 per share in the fourth quarter of 2012. Loss before income taxes was $3,271,000 compared to $4,462,000 for the same period last year. For the year, the company reported revenues were $38.8 million, an increase of $18.1 million over 2012 full year revenues of $20.7 million. LBITDA for 2013 was $6.8 million compared to $12.7 million in 2012. Adjusted LBITDA was $5.7 million compared to $12.1 million in the prior year. Net loss was $8.7 million or $2.26 per share in comparison to a $14.9 million net loss or $8.44 per share for full year 2012. Loss before income taxes was $8,572,000 compared to $15,034,000 for the same period last year. For the first quarter of 2014, the company expects to report revenues of between $11.4 and $11.9 million. For the full year 2014, the company expects to report revenues of between $47 and $50 million.

Oxford Immunotec Global PLC Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 02:40 PM

Oxford Immunotec Global PLC Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 02:40 PM. Venue: The Waldorf Astoria Hotel, New York, New York, United States. Speakers: Mark Klausner, Investor Relations, Peter Wrighton-Smith, Chief Executive Officer and Director, Richard M. Altieri, Chief Financial Officer and Principal Accounting Officer.

Oxford Immunotec Global PLC Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-05-2014 11:20 AM

Oxford Immunotec Global PLC Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-05-2014 11:20 AM. Venue: Marriott Copley Place Hotel, Boston, Massachusetts, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXFD:US $17.98 USD +0.11

OXFD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
QIAGEN NV €14.80 EUR -0.043
View Industry Companies
 

Industry Analysis

OXFD

Industry Average

Valuation OXFD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.0x
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXFORD IMMUNOTEC GLOBAL PLC, please visit www.oxfordimmunotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.